Plus Therapeutics, Inc. · NASDAQ:PSTV
Guse Kyle exercised options for 922 Plus Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 1, 2026
On Jul 1, 2026, Guse Kyle (Director) exercised options for 922 Plus Therapeutics, Inc. shares, leaving 922 shares. Filed Jul 1, 2026 (Form 4).
- Options exercised
- 922 shares
- Holding after
- 922 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 922 | 922 | Direct |